Aion Therapeutic Inc. reported earnings results for the third quarter and nine months ended January 31, 2024. For the third quarter, the company reported sales was CAD 0.222043 million. Net loss was CAD 0.377954 million compared to CAD 0.215721 million a year ago. Basic loss per share from continuing operations was CAD 0.001 compared to CAD 0.0015 a year ago.
For the nine months, sales was CAD 0.222043 million. Net loss was CAD 0.887893 million compared to CAD 0.047984 million a year ago. Basic loss per share from continuing operations was CAD 0.004 compared to CAD 0.001 a year ago.